Abdel-Fatah, T., Rees, R., Pockley, A., Moseley, P., Ball, G., Chan, S., … Miles, A. (2017). The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2. Oncotarget, 8(68), 112245-112257. https://doi.org/10.18632/oncotarget.22496 (Original work published 2017)
IO Ellis
First name:
IO
Last name:
Ellis
Wolff, A., Hammond, M., Allison, K., Harvey, B., Mangu, P., Bartlett, J., … Dowsett, M. (2018). Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 36(20), 2105-2122. https://doi.org/10.1200/JCO.2018.77.8738 (Original work published 2018)
Wolff, A., Hammond, M., Allison, K., Harvey, B., Mangu, P., Bartlett, J., … Dowsett, M. (2018). Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. Archives of Pathology & Laboratory Medicine. https://doi.org/10.5858/arpa.2018-0902-SA (Original work published 2018)
